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Abstract:
Background:
Organotin(IV)  derivatives  have  appeared  recently  as  potential  biologically  active  metallopharmaceuticals  exhibiting  a  variety  of  therapeutic
activities. Hence, it is important to study the synthesis of new organotin compounds with low toxicity that may be of pharmacological interest.
Objectives:
This study focuses on the synthesis of new bis-stannylated derivatives with C2 symmetry that could be tested as antifungal agents against two
clinical important fungal species, Cryptococcus neoformans and Candida albicans.
Methods:
The radical addition of triorganotin hydrides (R3SnH) and diorganotin chlorohydrides (R2ClSnH) to bis-α,β-unsaturated diesters derived from (S)-
BINOL led to the corresponding new bis-stannylated derivatives with C2  symmetry.  Nine pure organotin compounds were synthesized with
defined stereochemistry. Four of them were enantiomerically pure and four were diastereoisomeric mixtures.
Results:
All new organotin compounds were fully characterized, those with phenyl ligands bonded to tin were the most active compounds against both the
strains (Cryptococcus neoformans and Candida albicans), with activity parameters of IC50 close to those of the reference drug (amphotericin B).
Conclusion:
Nine pure organotin compounds with C2 symmetry were synthesized with defined stereochemistry and their antifungal properties were tested
against two clinical important fungi with IC values close to those of the reference drug. The structure-containing preferably two or three phenyl
groups joined to the tin atom were highly active against both the strains compared with those possessing tri-n-butyl groups.
Keywords:  C2  symmetry,  Bis-stannylated (S)-BINOL derivatives,  Bis-chlorostannanes,  Radical  hydrostannation,  Cryptococcus neoformans,
Cryptococcus neoformans.
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1. INTRODUCTION
Organotin  compounds have been used for  many years  in
different applications, for example as catalysts, heat and light
stabilizers,  additives  of  PVC,  antifouling,  antimold  and
germicidal agents [1 - 5].  After near  170 years  of their  disco-
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very, Tin(IV) organic compounds are one of the most impor-
tant concerning organometallic chemistry researches [6 - 10].
Their toxicity depends on the alkyl group, decreasing with the
increase in the alkyl chain length [11]. In the last fifteen years,
organotin(IV)  derivatives  have  appeared  also  as  potential
biologically  active  metallopharmaceuticals  exhibiting  anti-
tumor,  antibacterial,  anti-inflammatory  and  antimicrobial
activity  [12,  13].  Considering  the  limitations  caused  by  its
toxicity, it is important to develop new organotin compounds
34
DOI: 10.2174/1874842201906010034, 2019, 6, 34-46
Synthesis, Characterization and Antifungal Assessment Open Chemistry Journal, 2019, Volume 6  ??
that  could  be  safer  and  more  effective  for  chemotherapeutic
uses.
Taking  into  account  that  bis-chlorostannanes  Ph2ClSn–
R–SnClPh2  show  interesting  biological  activities  [14],  we
present  here  the  synthesis  and  antifungal  assessment  of
optically active organotin compounds derived from (S)-BINOL
as part of our research work on the behavior of C2 symmetry
diol diesters in radical hydrostannations [15]. The aim of these
studies  was  to  determine  the  scope  and  limitations  of  the
change  in  the  structural  core  of  the  chiral  diol  over  the
stereoselectivity  in  the  radical  tandem cyclohydrostannation,
which lead to eleven-membered macrodiolides [16 - 18]. The
starting  materials  for  building  these  cycles  are  open  chain
systems  with  two  carbon-carbon  double  bonds  activated  for
radical addition by electron withdrawing substituents like the
ester group, as shown in Fig. (1). The chiral cores employed in
these studies were TADDOL (I) and (11R,12R)-9,10-dihydro-
9,10-ethaneanthracene-11,12-dimethanol  (II),  both  C2
symmetry  diols.  Now,  in  the  present  study,  we  added  (S)-
BINOL (III).
1,1’-Bi-2-naphthol  (BINOL)  is  an  axially  chiral  organic
compound that can be found as a racemic mixture or in its two
atropoisomeric forms: M or (R) and P or (S) (Fig. 2). Since the
chirality axis is not affected in the esterification reactions, the
(S)-BINOL  derivatives  retain  such  configuration  and  optical
purity.
The  internal  relative  spatial  arrangement  of  bioactive
molecules is crucial regarding their ability to interact favorably
with  active  and  allosteric  sites.  Although  since  1990,  single
enantiomers  have  clearly  dominated  over  racemates  in  the
Drug Discovery and Regulatory Agency approval trends [19],
it is surprising that biologically active atropoisomers have not
been  extensively  covered  in  the  literature,  despite  their
prevalence  and  importance  to  the  pharmaceutical  industry.
There are several well-documented atropoisomeric compounds
with demonstrated utility as effective drugs. Among them, it is
worth mentioning that the glycopeptide P-isomer vancomycin
is  often  used  as  a  drug  of  penicillin-resistant  bacterial
infections.  It  is  produced  by  the  soil  bacteria  Amycolatopsis
orientalis,  and  exhibits  broad-spectrum  activity  against  a
number  of  gram-positive  bacteria  [20].  Another  example  is
gossypol that is produced by Gossypium hirsutum, which has
been shown to have possible applications as an antifertility and
anticancer agent through binding to antiapoptotic protein Bcl-X
L [21]. It has recently been shown that the active atropoisomer
of  gossypol  is  that  of  the  M-(-)-enantiomer  [22].  As  an
antecedent  of  antifungal  activity,  the  atropoisomeric  flavans
myristinins,  isolated  from  Myristica  cinnamomea  fruits,
showed antifungal activity against Candida albicans with IC50
values ranging from 5.9 to 8.8 µg/mL [23].
In the last decades, fungi have emerged as a major cause of
human  morbidity  and  mortality,  mainly  among  the  immuno-
compromised and seriously ill-hospitalized patients [24]. Most
of the mycoses-related deaths are associated with the spp. C.
albicans and Cryptococcus neoformans and although there are
several  antifungal  drugs  in  clinical  use  to  fight  against  this
opportunistic  fungal  spp,  the  fungal  infections  remain  very
difficult to eradicate. C. albicans is among the most common
cause  of  opportunistic  fungal  infections  in  immunocom-
promised hosts. C. neoformans is the most frequent cause  of
meningitis and  is one of the most  important
HIV-related fatal opportunistic mycoses, which has killed more
than 650,000 immunocompromised patients worldwide up to
date [25].  Besides, C. neoformans  remains an important life-
threatening  complication,  particularly  for  immunocom-
promised patients who have undergone transplantation of solid
organs  and  therefore,  new  compounds  acting  against  this
fungus are highly welcome [26]. Although the incidence of the
disease  tends  to  decline  in  countries  with  highly  active
antiretroviral therapy, the outcome of infection is influenced by
a variety of factors including the antifungal resistance and new
strategies including new structural types with anti-cryptococcal
activity are highly welcome [27].
In  this  work,  the  synthesized  atropoisomers  (S)-3,  (S)-4,
(S)-8, (S)-9 and the diastereomeric mixtures 5a-d, 6a-d, 10a-d,
11a-d  were  tested  as  antifungal  agents  against  the  two
mentioned  clinical  important  fungal  species,  C.  neoformans
and C. albicans.
Fig. (1). System of two activated carbon-carbon double bonds linked by a C2 chiral core.
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Fig. (2). M or (R) and P or (S) BINOL atropoisomers.
2. MATERIALS AND METHODS
Unless otherwise noted, all the reagents were purchased in
analytical reagent grade from commercial suppliers and used
without purification. All the reactions were carried out under
inert atmosphere. The solvents used were distilled and dried in
accordance  with  standard  procedures.  Di-n-butyl-  and  diph-
enyltin  dihydride  were  obtained  by  the  reduction  of  the
corresponding dichloride with lithium aluminum hydride [28]
and the starting BINOL unsaturated diesters were prepared as
described  previously  [15].  Thin  layer  chromatography  was
performed on Merck silica gel 60 F254 plates and visualization
was accomplished with UV light and/or 5% ethanol solution of
phosphomolybdic acid. Silica gel (Merck, 230–400 mesh) was
used  for  column  chromatography.  Melting  points  were
recorded on a Büchi Melting Point B-545 instrument and are
uncorrected. NMR spectra were recorded on a Bruker Avance
300  Multinuclear  instrument,  using  CDCl3  as  a  solvent;
chemical shifts (δ) were reported in ppm with respect to TMS
in  1HNMR and  13CNMR,  and  with  respect  to  Me4Sn in  the
case  of  119SnNMR  spectra.  Data  were  reported  as  follows:
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet,
q  =  quartet,  quin  =  quintuplet,  sex  =  sextet  and  br  =  broad),
coupling  constant  (J  values  in  Hz)  and  integration.Chemical
shifts (δ) are reported in ppm and coupling constants (J) are in
Hz. Infrared spectra were recorded with a Nicolet Nexus 470
FT spectrometer. Optical rotations were measured on a Polar
L-P,  IBZ  Messtechnik  polarimeter  at  589  nm.  Compounds
described  here  were  characterized  by  1H,  13C  and  DEPT-
NMR. Elemental analyses (C, H) were performed in an Exeter
analytical, Model CE440 Analyzer.
2.1.  General  Procedure  for  the  Addition  of  Triorganotin
Hydrides  to  BINOL  Unsaturated  Diesters  Initiated  by
AIBN  at  75°C
Diester  (1 mmol),  triorganotin hydride (2.4 mmol)  and a
catalytic amount of AIBN were stirred in dry toluene (24 mL)
at 75°C for 1 hour. The reaction was monitored by TLC and IR
spectroscopy. The solvent was then distilled off under reduced
pressure. The crude product was thus obtained directly purified
by column chromatography using silica gel.
2.1.1.  (S)-1,1'-binaphthalene-2,2'-diyl-bis[3-(tri-n-buthyles-
tannyl)propanoate] (S)-3
The  product  (S)-3  was  eluted  with  hexane/ethyl  acetate
(98:2) as a yellow oil in a 67% yield. [α]D
25 -11.33 (c = 0.45,
CHCl3). 1HNMR (300 MHz,CDCl3) δ: 0.71-0.88 (m, 6 x CH2,
6 x CH3, 30H), 0.86-1.00 (m, 6 x CH2, 12H), 1.11-1.31 (m, 6 x
CH2,  12H), 1.40 (t,  
2J(H,  Sn)= 60.57, Hz, 
3J(H,H)= 8.71, 2 x CH2,
4H),  2.46  (t,  3J(H,  Sn)=  11.8,  Hz,  
3J(H,H)=  8.71,  2  x  CH2,  4H),
7.03-7.12 (m, Ar-H, 4H), 7.15-7.37 (m, Ar-H, 6H), 7.77-7.99
(m, Ar-H, 2H). 13CNMR (75.4 MHz, CDCl3) δ: 2.72 (468.8),
8.83 (323.2),  13.80,  27.39 (56.3),  29.14 (19.5),  31.17 (16.4),
110.82,  117.76,  124.04,  124.20,  127.48,  128.41,  129.45,
131.43, 133.39, 151.74, 173.62 (64.2). 119SnNMR (CDCl3) δ:
-7.39  ppm.  Anal.  Calcd.  for  C50H74O4Sn2:  C,  61.50,  H,  7.64.
Found: C, 61.64, H, 7.70.
2.1.2.  (S)-1,1'-binaphthalene-2,2'-diyl-bis[3-(triphenylesta-
nnyl)propanoate] (S)-4
The  product  (S)-4  was  eluted  with  hexane/ethyl  acetate
(90:10) as colourless oil in a 86% yield. [α]D
25 -11.09 (c=0.82,
CHCl3). 1HNMR (300 MHz, CDCl3) δ: 1.41 (t, 
2J(H,  Sn)= 61.8,
Hz, 3J(H,H)= 7.42 Hz, 2 x CH2, 4H), 2.51 (t, 
3J(H,H)= 7.42 Hz, 2 x
CH2, 4H), 7.23 (d, 
3J(H,H)= 8.9 Hz, Ar-H, 2H), 7.36-7.45 (m, Ar-
H, 4H), 7.46-7.58 (m, Ar-H, 20H), 7.62-7.65 (m, Ar-H, 12H),
7.97-8.00 (m, Ar-H, 4H). 13CNMR (75.4 MHz, CDCl3) δ: 5.02
(390.1), 29.34 (18.4), 122.03, 123.44, 125.35, 125.72, 126.13,
126.74, 128.54, 128.85, 128.97, 129.06, 131.48, 133.36, 137.06
(35.3),  137.48,  138.28  (504.5),  146.81,  171.42  (64.9).
119SnNMR  (CDCl3)  δ:  -99.05  ppm.  Anal.  Calcd.  for
C62H50O4Sn2:  C,  67.91,  H,  4.60.  Found:  C,  68.05,  H,  4.67.
2.1.3.  1,1'-binaphthalene-2,2'-diyl-bis[2-methyl-3-(tri-n-but-
hylestannyl)propanoate] (5a-d, 5a-b)
The  mixture  of  5a-d  was  eluted  with  hexane/ethyl  ether
(97:3) as a white solid in a 67% yield. By re-chromatography,
the  diastereomers  5a-b  were  eluted  with  hexane/ethyl  ether
(96:4)  as  a  white  solid  in  a  34% yield  in  a  61:39 ratio  [d.e.:
22%]. 1HNMR (300 MHz, CDCl3) δ: 0.46 (dd, 
3J(H,H)= 6.9 Hz,
2J(H,H)= 2.3 Hz, 4 x CH2,  8H),  0.60-0.67 (m, 12 x CH2,  24H),
0.81 (t, 3J(H,H)= 7.3 Hz, 12 x CH3, 36H), 1.11-1.22 (m, 4CH3 y
12CH2, 36H), 1.23-1.33 (m, 12 x CH2, 24H), 2.23-2.42 (m, 4 x
CH, 4H), 7.21-4.23 (m, Ar-H, 8H), 7.28-7.42 (m, Ar-H, 8H),
7.77-7.93 (m, Ar-H, 8H). 13CNMR (75.4 MHz, CDCl3) δ: 9.39
(309.9), 9.41 (323.6), 12.27 (281.5), 13.84, 19.73 (22.8), 27.32
(55.5), 29.20 (17.0), 37.30 (23.6), 37.33 (20.2), 122.11, 123.81,
123.83,  125.70,  126.27,  126.76,  127.93,  129.30,  129.34,
131.59,  131.61,  133.56,  133.60,  147.02,  175.91,  175.92.
119SnNMR  (CDCl3)  δ:  -11.34,  -11.82.  Anal.  Calcd.  for
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C52H78O4Sn2:  C,  62.17,  H,  7.83.  Found:  C,  62.32,  H,  7.89.
2.1.4.  1,1'-binaphthalene-2,2'-diyl-bis[2-methyl-3-(triphenyl-
estannyl)propanoate] (6a-d)
The mixture of 6a-d was eluted with hexane/ethyl acetate
(95:5)  as  a  white  solid  in  a  84% yield.  1HNMR (300  MHz,
CDCl3) δ: 0.42-0.60 (m, 8 x CH3, 24H), 0.84-1.08 (m, 8 x CH2,
16H), 2.39-2.66 (m, 8 x CH, 8H), 6.92-7.12 (m, Ar-H, 16H),
7.38-7.55  (m,  Ar-H,  64H),  7.59-7.70  (m,  Ar-H,  56H),
7.84-7.93  (m,  Ar-H,  32H).  13CNMR (75.4  MHz,  CDCl3)  δ:
13.59, 13.62, 13.70, 13.72, 18.29, 35.34, 35.29, 35.27, 35.23,
120.22,  120.25,  120.29,  120.31,  121.72,  121.75,  123.90,
123.94,  124.25,  124.26,  124.36,  124.90,  124.92,  126.13,
126.18,  126.41,  126.39,  126.74,  126.94,  126.99,  127.06,
127.11,  127.13,  129.68,  129.71,  129.73,  131.54,  131.56,
131.61,  131.62,  153..33,  135.71,  136.98,  137.01,  137.03,
137.36,  144.95,  144.09,  145.01,  173.29,  173.34,  173.38,
173.41.  119SnNMR  (CDCl3)  δ:  -103.24,  -103.61,  -103.74,
-103.91.  Anal.  Calcd.  for  C64H54O4Sn2:  C,  68.36,  H,  4.84.
Found:  C,  68.53,  H,  4.94.
2.2.  General  Procedure  for  the  Addition  of  di-n-butyltin
Chlorohydride  to  BINOL  Unsaturated  Diesters  Initiated
with AIBN at 40°C (METHOD A) [17]
Di-n-butyltin  dichloride  (0.18  g,  0.61  mmoles)  was
dissolved in dry toluene (3.4 mL), and di-n-butyltin dihydride
(0.12 mL, 0.14 g, 0.61 mmoles) was added. The mixture was
stirred  for  about  30 min,  with  monitoring the  reaction by IR
spectroscopy  to  verify  the  formation  of  di-n-butyltin  chlo-
rohydride.  Then,  a  solution  of  diester  (0.51  mmoles)  in  dry
toluene  (5.7  mL)  was  added  with  a  syringe  slowly  to  the
mixture  together  with  a  catalytic  amount  of  azo-bis-
isobutyronitrile  (AIBN)  as  a  radical  initiator.  The  reaction
mixture was heated to 40° C and was monitored by TLC and
IR spectroscopy. After one hour, the solvent was then distilled
off  under  reduced pressure.  The crude product  thus  obtained
was directly purified by column chromatography using silica
gel 60.
2.3.  General  Procedure  for  the  Addition  of  Diphenyltin
Chlorohydride  to  BINOL  Unsaturated  Diesters  Initiated
with AIBN at 40°C (METHOD A) [17]
Diphenyltin  dichloride  (0.21  g,  0.61  mmoles)  was
dissolved  in  dry  toluene  (1  mL),  and  diphenyltin  dihydride
(0.12 mL, 0.17 g, 0.61 mmoles) was added. The mixture was
stirred for about 1 hour, monitoring the reaction by IR spect-
roscopy to verify the formation of diphenyltin chlorohydride.
Then, a solution of diester (0.51 mmoles) in dry toluene (5.7
mL) was added with a syringe slowly to the mixture together
with a catalytic amount of azo-bis-isobutyronitrile (AIBN) as a
radical initiator. The reaction mixture was heated to 40°C and
was monitored by TLC and IR spectroscopy. After one hour,
the solvent was then distilled off under reduced pressure. The
crude product  thus obtained was directly  purified by column
chromatography using silica gel 60.
2.4.  Procedure  for  the  Addition  of  di-n-butyltin
Chlorohydride to BINOL Dimethacrylate Diesters at −78°C
Initiated with Et3B (METHOD B) [17, 34]
Di-n-butyltin  dihydride  (0.12  mL,  0.14  g,  0.61  mmoles)
was added to a solution of di-n-butyltin dichloride (0.18 g, 0.61
mmoles)  in  dry toluene (3.4 mL) at  room temperature.  After
being  stirred  for  30  min,  the  formation  of  the  di-n-butyltin
chlorohydride was verified by IR and the mixture was cooled
to −78°C. A solution of diester (S)-1b (0.21 g, 0.51 mmoles) in
dry toluene (5.7 mL) was added with a syringe slowly to the
mixture. Immediately, Et3B (0.10 mmoles, 0.0099 g, 0.011 mL)
was added and the mixture was stirred at −78°C for 8 h with
monitoring  by  TLC  and  IR  spectroscopy.  The  solvent  was
distilled off under reduced pressure.
2.5.  Procedure  for  the  Addition  of  Diphenyltin
Chlorohydride to BINOL Dimethacrylate Diesters at −78°C
Initiated with Et3B (METHOD B) [17, 34]
Diphenyltin dihydride (0.11 mL, 0.16 g, 0.57 mmoles) was
added  to  a  solution  of  diphenyltin  dichloride  (0.19  g,  0.57
mmoles)  in  dry toluene (0.5 mL) at  room temperature.  After
being  stirred  for  1  hour,  the  formation  of  diphenyltin
chlorohydride was verified by IR and the mixture was cooled
down  to  −78°C.  A  solution  of  diester  (0.47  mmoles)  in  dry
toluene  (4.5  mL)  was  added  with  a  syringe  slowly  to  the
mixture.  Immediately,  Et3B  (0.094  mmoles,  0.0092  g,  0.010
mL) was added and the mixture was stirred at −78°C for 10 h
with monitoring by TLC and IR spectroscopy. The solvent was
distilled off under reduced pressure.
2.5.1.  (S)-1,1'-binaphthalene-2,2'-diyl-bis[3-(chlorodi-n-but-
hylestannyl)propanoate] (S)-8 Method A
The  product  (S)-8  was  eluted  with  hexane/ethyl  acetate
(98:2) as a yellow oil in a 65% yield. [α]D
25 +170.80 (c=0.020,
CHCl3). 1HNMR (300 MHz,CDCl3) δ: 0.77 (dd, 
3J(H,H)= 7.3 Hz,
2CH2, 4H), 0.83 (dd, 
3J(H,H)= 7.3 Hz, 2CH2, 4H), 1.06-1.39 (m, 4
x CH3, 4 x CH2, 20H), 1.43-4.56 (m, 4 x CH2, 8H), 2.22-2.33
(m, 2 x CH2, 4H), 2.49-2.60 (m, 2 x CH2, 4H), 7.02-7.33 (m,
Ar-H, 6H), 7.43 (dt, 3J(H,H)= 8.2 Hz, 
4J(H,H)= 1.8 Hz, Ar-H, 2H),
7.89 (d, 3J(H,H)= 8.2 Hz, Ar-H, 2H), 7.43 (d, 
3J(H,H)= 8.2 Hz, Ar-
H, 2H). 13CNMR (75.4 MHz, CDCl3) δ: 11.59 (388.6), 13.81,
18.11 (647.0), 18.80, 26.88 (85.1), 27.86 (41.1), 29.96 (27.2),
120.83,  123.06,  126.24,  126.46,  127.40,  128.39,  130.48,
131.92, 133.06, 146.34, 178.77 (24.4). 119SnNMR (CDCl3) δ:
85.88 ppm. Anal. Calcd. for C42H56Cl2O4Sn2: C, 54.06, H, 6.05.
Found: C, 54.24, H, 6.12.
2.5.2.  (S)-1,1'-binaphthalene-2,2'-diyl-bis[3-(chlorodipheny-
lestannyl)propanoate] (S)-9 Method A
The  product  (S)-9  was  eluted  with  hexane/ethyl  acetate
(98:2) as a yellow oil in a 95% yield. [α]D
25 +36.32 (c=0.038,
CHCl3). 
1HNMR (300 MHz, CDCl3) δ: 1.26-1.30 (m, CH2, 2H),
1.30-1.40 (m, CH2, 2H), 2.16-2.28 (m, 2 x CH2, 4H), 6.83-7.07
(m, Ar-H, 8H), 7.21-7.42 (m, Ar-H, 20H), 7.82-7.89 (m, Ar-H,
4H).  13CNMR  (75.4  MHz,  CDCl3)  δ:  13.04  (513.0),  29.38
(32.8), 120.72, 122.57, 125.30, 125.64, 126.38, 127.31, 128.22,
128.58,  129.10,  129.17,  129.65,  130.14,  130.49,  131.66,
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132.723,  136.11  (45.3),  146.13,  179.36  (43.6).  119SnNMR
(CDCl3) δ: -52.55. Anal. Calcd. for C50H40Cl2O4Sn2: C, 59.27,
H, 3.98. Found: C, 59.45, H, 4.07.
2.5.3. 1,1'-binaphthalene-2,2'-diyl-bis[3-(chlorodi-n-buthyles-
tannyl)-2-methyl propanoate] (10a-d) Method A
The  mixture  of  diastereoisomers  10a-d  was  isolated  by
column chromatography  using  silica  gel  60  as  the  stationary
phase eluting as a yellow oil with a mixture of hexane: ethyl
acetate  (90:10)  in  a  78%  yield.  Method  B.  The  mixture  of
diastereoisomers  10a-d  was  isolated  by  column  chroma-
tography using silica gel 60 as the stationary phase eluting as a
yellow oil with a mixture of hexane: ethyl acetate (90:10) in a
40% yield. 1HNMR (300 MHz, CDCl3) δ: 0.18 (d, 
3J(H,H)= 7.2
Hz, 2 x CH3, 6H), 0.30 (d, 
3J(H,H)= 7.2 Hz, 2 x CH3, 6H), 0.59
(d, 3J(H,H)= 7.2 Hz, 2 x CH3, 6H), 0.76-0.91 (m, 2CH3, 4 x 2CH2,
22H),  1.04-1.84 (m,  4  x  12CH2,  4  x  4CH3,  144H),  2.37-2.91
(m, 4 x 2CH, 8H), 7.04-7.32 (m, Ar-H, 24H), 7.40-7.45 (m, Ar-
H,  8H);  7.86-7.97  (m,  Ar-H,  16H).  13CNMR  (75.4  MHz,
CDCl3)  δ:  12.68,  18.33,  18.63,  18.90,  19.00,  20.55,  20.56,
20.73, 20.85, 25.43, 25.57, 26.08, 26.28, 31.27, 31.87, 35.55,
35.62,  35.66,  35.74,  119.65,  121.97,  124.74,  125.32,  126.22,
127.20,  129.07,  130.71,  131.82,  145.12,  180.03,  180.28,
180.35,  180.61.  119SnNMR (CDCl3)  δ:  72.95,  70.09,  69.68,
68.72.  Anal.  Calcd.  for  C44H60Cl2O4Sn2:  C,  54.98,  H,  6.29.
Found: C, 55.12, H, 6.35.
2.5.4.  1,1'-binaphthalene-2,2'-diyl-bis[3-(Chlorodiphenylest-
annyl)-2-methyl Propanoate] (11a-d) Method A
The  mixture  of  diastereoisomers  11a-d  was  purified  by
column chromatography  using  silica  gel  60  as  the  stationary
phase eluting as a yellow oil with a mixture of hexane: ethyl
acetate  (98:2)  in  a  96%  yield.  Method  B.  The  mixture  of
diastereoisomers  11a-d  was  isolated  by  column  chroma-
tography using silica gel 60 as the stationary phase eluting as a
yellow oil with a mixture of hexane: ethyl acetate (98:2) in a
65% yield. 1HNMR (300 MHz, CDCl3) δ: 0.04 (d, 
3J(H,H)= 7.2
Hz, 2 x CH3, 6H), 0.19 (d, 
3J(H,H)= 7.2 Hz, 2 x CH3, 6H), 0.28
(d,  3J(H,H)= 7.2 Hz,  2 x CH3,  6H),  0.44 (d,  
3J(H,H)= 7.2 Hz,  2 x
CH3,  6H),  0.89-1.34  (m,  4  x  2CH2,  16H),  2.32-2.78  (m,  4  x
2CH,  8H),  6.61-7.22  (m,  Ar-H,  112H),  7.78-7.88  (m,  Ar-H,
16H).  13CNMR  (75.4  MHz,  CDCl3)  δ:  18.78,  19.08,  19.18,
19.32, 23.32, 23.40, 36.45, 36.53, 36.60, 36.73, 118.77, 118.93,
119.00,  120.74,  120.94,  121.28,  123.60,  123.71,  123.78,
123.83,  124.63,  124.73,  124.78,  125.60,  125.70,  126.81,
127.42,  127.85,  128.26,  128.75,  129.91,  129.99,  130.11,
130.99,  131.01,  131.08,  134.41,  144.20,  144.29,  144.31,
144.36, 181.25, 181.63, 181.75, 181.85. 119SnNMR (CDCl3)
δ:  -63.69,  -66.73,  -68.68,  -70.39.  Anal.  Calcd.  for
C52H44Cl2O4Sn2: C, 59.98, H, 4.26. Found: C, 60.12, H, 4.34.
2.6.  Biology,  Antifungal  Evaluation,  Microorganisms  and
Media
For the antifungal  evaluation,  the standardized strains C.
albicans ATCC 10231 and C. neoformans ATCC 32264 from
the  American  Type  Culture  Collection  (ATCC),  Rockville,
MD,  USA  were  used.  Strains  were  grown  on  Sabouraud-
chloramphenicol  agar slants  for  48 h at  30°C, maintained on
slopes of Sabouraud-dextrose Agar (SDA, Oxoid), and subcul-
tured every 15 days  to  prevent  pleomorphic  transformations.
Inocula  of  the  cell  or  spore  suspensions  were  obtained
according  to  reported  procedures  and  adjusted  to  1-5x  103
cells/spores  with  colony  forming  units  (CFU)/mL.
2.7. Antifungal Susceptibility Testing
Minimum Inhibitory Concentration (MIC) of each extract
or  compound  was  determined  by  using  broth  microdilution
techniques  according  to  the  guidelines  of  the  National
Committee for Clinical Laboratory Standards for yeasts (M27-
A3).  MIC  values  were  determined  in  RPMI-1640  (Sigma-
Aldrich, St Louis, MO, USA), buffered to pH 7.0 with MOPS.
Microtiter  trays  were  incubated  at  35°C  in  a  moist,  dark
chamber,  and  MICs  were  visually  recorded  at  48  h.  For  the
assay,  stock  solutions  of  pure  compounds  were  two-fold
diluted with RPMI from 256 to 3.9 µg/mL (final volume = 100
µL) and a final DMSO concentration ≤ 1%. A volume of 100
µL of  inoculum suspension was added to  each well  with  the
exception of the sterility control where sterile water was added
to the well instead. Amphotericin B (Sigma Aldrich) was used
as  a  positive  control.  Endpoints  were  defined  as  the  lowest
concentration  of  drug  resulting  in  total  inhibition  (MIC)  of
visual  growth  compared  to  the  growth  in  the  control  wells
containing no antifungal.  The IC50  was defined as the lowest
concentration of a compound that produced 50% reduction in
the growth control (culture media with the microorganism but
without  the  addition  of  any compound),  and was  determined
spectrophotometrically  with  the  aid  of  a  VERSA  Max
microplate reader (Molecular Devices, Sunnyvale, CA, USA)
and  the  %  of  inhibition  for  each  compound  at  the  different
concentrations  was  calculated  as  follows:  100x  (OD (optical
density) 405 MTW - OD 405 SCW)/(OD 405 GCW - OD 405
SCW). Tests were conducted in triplicate.
2.8. X-ray Diffraction Analysis
The X-ray data were collected at 293(2) K with a Nonius
Kappa-CCD with Mo source diffractometer. The used software
for data collection included: APEX3: Bruker (2017). APEX3.
Bruker  AXS  Inc.,  Madison,  Wisconsin,  USA;  for  structure
solution SHELXT [29] and for structure refinement SHELXL
[30]. All H atoms bonded to carbon were placed with idealized
geometry and refined using riding model with C--H = 0.95 Å,
Uiso(H)  = 1.2  Ueq(C)  for  CH.  The absolute  configuration was
determined  by  the  Flack  parameter  and  was  assumed  to  be
unchanged  during  the  reaction  and  was  not  determined  by
diffraction methods.  The structural  data  have been deposited
with Cambridge Crystallographic Data Centre, CCDC number
CCDC  1589534.  Crystallographic  data  of  (S)-1e  for  the
structural  analyses  have  been  deposited  with  the  Cambridge
Crystallographic Data Centre, CCDC 1589534. Copies of this
information may be obtained free of charge from the Director,
CCDC,  12  Union  Road,  Cambridge,  CB21EZ,  UK,  fax:  +44
1223 336 033; email deposit@ccdc.cam.ac.uk or www:http://
www.ccdc.cam.ac.uk.
3. RESULTS AND DISCUSSION
Based on our previous results [16 - 18], we assumed that
the radical hydrostannation  of (S)-BINOL unsaturated  diesters
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Scheme (1). Radical addition of triorganotin hydrides to (S)-BINOL unsaturated diesters.
Fig. (3). X-ray structure of diester (S)-1e.
(S)-1a-e  could  lead  to  additional  products  to  one  or  both
olefinic  systems (compounds  type  A  or  B,  Scheme 1)  or  the
corresponding cycloadducts (compounds type C, Scheme 1).
After  performing  the  reaction  between  (S)-1,1'-bina-
phtyl-2-2'-diyl-diacrylates ((S)-1a-e) and the corresponding tri-
n-butyl- and triphenyltin hydrides under already known radical
conditions [16 - 18, 31],  (anhydrous toluene, 1:1,2 substrate/
organotin hydride relation, inert atmosphere, 75°C and AIBN
as radical initiator) only mixtures of type A and/or B adducts
were  formed  when  substrates  (S)-1a  and  (S)-1b  were
employed. No reaction was observed with (S)-1c to (S)-1e, and
the expected cyclized structure C was not observed in any case.
The (S)-BINOL diester spatial arrangement could explain these
results.  This  molecule,  with  C2  symmetry,  adopts  preferably
the transoid conformation, where the bulky substituents located
in positions 2 and 2' mutually move away. Thus, the olefinic
groups  are  arranged  opposite  to  the  other  and,  therefore,  the
formation  of  the  macrocycle  is  disfavored.  This  structural
arrangement was confirmed through X-ray diffraction analysis
of  dicinnamate  (S)-1e  which  produced  suitable  crystals  that
would confirm this approach (Fig. 3). Dicinnamate (S)-1e was
obtained  following  the  procedure  of  reference  13.  (See
Supporting Information for X-Ray diffraction analysis). Crystal
structural  data  was  deposited  at  the  Cambridge
Crystallographic Data Centre with Deposition number: CCDC
1589534.
Increasing the proportion of organotin hydride, the optimal
substrate  /  R3SnH  relation  determined  in  order  to  obtain  a
higher  proportion  of  type  B  bis-trialkyltin  addition  products
was  1:2,4  under  the  previously  mentioned  conditions.  TLC
chromatographic monitoring of the reaction showed that they
were  completed  after  one  hour.  Electronic  and  steric  factors
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usually  determine  the  rate  of  addition  to  olefins  and  in  both
cases, the alkene has the ester group as an activating electron-
withdrawing group and the β-carbon is unsubstituted so there is
no  steric  hindrance  for  the  regioselective  binding  of  the
trialkylstannyl group to the terminal carbon. However, this last
factor would affect diesters (S)-1c to (S)-1e, which remained
unreacted after 10 h. Table 1 summarizes the results obtained
in the radical hydrostannation of the reactive substrates (S)-1a
and (S)-1b.
The reaction with Bu3SnH with the diester (S)-1a, gave a
89% mixture of mono- and di-addition products (S)-2 and (S)-3
in a 31:69 proportion respectively which could be separated by
chromatography  although  with  low  final  yield  of  pure  bis-
stannylated  adduct  (S)-3  (Table  1,  entry  1,  67%,  Supporting
Information, Fig. S1). Increasing the substrate/Bu3SnH relation
to  1:3  provides  a  20:80  mixture  of  single  (A)  and  double
addition  products  (B)  but  in  lower  yield  (63%)  from  which
(S)-3 was obtained in a 45% yield. Type A adduct (S)-2 could
not be isolated in a pure form so it could not be characterized.
The same organotin  hydride  reacted  with  substrate  (S)-1b  to
yield in this case only bis-addition adducts 5a-d, obtained as a
mixture of four diastereomers in relation 50:13:25:12 (Table 1,
entry 3,  67%) from which it  was possible  to  separate  two of
them by re-chromatography, named 5a-b (34%), 119SnNMR
(δ, ppm) -11.34 and -11.82 (see Supporting Information, Fig.
S2 and experimental section).
The best yields were observed in the reaction with Ph3SnH
and only type B products were obtained. This can be attributed
to  the  higher  reactivity  and  higher  hydrogen  donating
capability  of  Ph3SnH  relative  to  Bu3SnH.  (S)-4  adduct  was
obtained as a single enantiomer in 86% yield after purification
(Table 1, entry 2; Supporting Information, Fig. S3), and 6a-d
were obtained in 84% yield, as a mixture of four diastereomers
in  8:19:42:31  relation,  that  could  not  be  separated  (Table  1,
entry  4;  Supporting  Information,  Fig.  S4).  All  the  obtained
double addition products were purified by chromatography and
characterized  by  1H,  13C  and  119SnNMR.  In  all  cases,  the
diastereomeric  composition  (%  D)  was  determined  from  the
119SnNMR spectra of the crude reaction products. Analysis of
1H  and  13CNMR  spectral  data  (Supporting  Information,
Tables S1-S4 and experimental section) confirms the structure
of type B adducts (S)-3, (S)-4, 5a-b and 6a-d, showing in the
13CNMR  spectrum  only  one  signal  with  3J(Sn,C)  coupling
constant, corresponding to C=O bond, for each stereoisomer.
Changing the organic ligand by halogen in the organotin
hydride determines novel derivatives with the general structure
of bis-halodiorganotin adduct and the differentiation of certain
molecular properties that would help further studies thereof [32
- 34].
As it is already known, a halogen atom as a ligand bound
to tin renders the latter more electropositive, which favors its
intramolecular coordination with the carbonyl in β- respective
to the ester group through a five-member cycle (Fig. 4) which
could determine a particular spectroscopic behavior [35].
Haloorganotin  derivatives  of  this  type  could  be  obtained
through  radical  addition  of  mixed  organotin  halohydrides
R2SnHX.  These  highly  reactive  tin  hydrides  undergo  radical
chain reactions at low temperature (−78°C to 40ºC) not higher
than 40°C in order to prevent their decomposition. Their higher
Lewis  acidity  (in  comparison  with  the  most  commonly  used
hydrostannylation reagent Bu3SnH or Ph3SnH) leads to much
better regio- and stereoselectivities.17  Considering the forma-
tion of an intermediate with intramolecular coordination during
the mechanistic steps of the radical halohydrostannation, this
could result in a higher stereoselectivity or differences in the
course of the reaction.
We  added  dialkyltin  chlorohydrides  R2SnHCl  (R=  n-Bu,
Ph) to the (S)-BINOL unsaturated diesters (S)-1a and (S)-1b,
and  then  analyzed  whether  substantial  changes  in  diastere-
oselectivity and yield were produced in the products obtained
(Scheme 2).  The mixed hydrides were prepared by exchange
reactions  between  an  equimolecular  mixture  of  R2SnH2  and
R2SnCl2 and used in-situ [36]. The halohydrostannations were
carried  out  under  inert  atmosphere  and  radical  conditions,
using  AIBN  as  radical  initiator,  using  2.4  equivalents  of
R2SnHCl  in  toluene  and  keeping  the  mixture  at  room
temperature  (Method  A)  [37].
Table 1. Radical hydrostannation of (S)-1a and (S)-1b.
Entry Diester R3SnH
Diester/R3SnH
Relation
A/ Ba
119SnNMR (δ, ppm)c Yield
(%) d
% De
(A)b Cpd. Nº (B)c Cpd. Nº
1
(S)-1a
n-Bu3SnH 1: 2.4 31/69 -7.08 (S)-2 -7.39 (S)-3 67 100
n-Bu3SnH 1: 3 20/80 -7.08 (S)-2 -7.39 (S)-3 45 100
2 Ph3SnH 1: 2.4 0/100 -
f - -99.05 (S)-4 86 100
3
(S)-1b
n-Bu3SnH 1: 2.4 0/100 -
f -
-11.34
-11.40
-11.82
-11.86
5a-d 67
50
13
25
12
4 Ph3SnH 1: 2.4 0/100 -
f -
-103.38
-103.73
-104.02
-104.20
6a-d 84
8
19
42
31
a Proportion of mono (A) and di-addition (B) products determined by integration in the 119SnNMR spectrum; b Single
addition adduct; c Double addition adduct; c Chemical shift determined in CDCl3 respect to Me4Sn; 
d Yield of the isolated
di-addition products; e Diastereomeric relationship determined by integration in the 119SnNMR spectrum; f Not observed
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Fig. (4). Five-member cycle intramolecular coordination in β-haloorganotin esters.
Scheme (2). Addition of dialkyltin chlorohydrides R2SnHCl to the unsaturated diesters (S)-1a and (S)-1b.
Table 2. Radical chlorohydrostannation of 1a and 1b by thermal induction (Method A).
Entry Diester -R S/D Products Relationa
119SnNMR (δ, ppm)b Yield
(%)e
%Df
(S)c (D)d Cpd. N°
1
(S)-1a
n-Bu 8/92
87.46
(S)-7
85.88 (S)-8 65 100
2 Ph 0/100 -g -52.55 (S)-9 95 100
3
(S)-1b
n-Bu 0/100 -g
72.95
70.09
69.68
68.72
10a-d 78
19
32
25
24
4 Ph 0/100 -g
-63.69
-66.73
-68.68
-70.39
11a-d 96
22
29
25
24
a By integration in the 119SnNMR spectrum; b Chemical shift determined in CDCl3 respect to Me4Sn;
c Single addition adduct; d Double addition adduct; e Yield of the isolated bis-addition product; f Diastereomeric relationship determined by integration in the 119SnNMR
spectrum of the crude reaction product; g No signals are observed.
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Except for the addition of n-Bu2SnHCl to (S)-1a where a
single  addition  product  was  detected  (Table  2,  entry  1),  the
reaction gave exclusively double addition products after  1 h.
Yields  were  almost  quantitative  for  Ph2SnHCl  addition  and
smaller for n-Bu2SnHCl probably due to its lower reactivity (H
donor  capability).  The diastereoisomeric  mixtures  10a-d  and
11a-d  could  not  be  separated  and  no  improvement  in
diastereoselectivity  was  observed  under  these  conditions.
Taking  into  account  that  the  stereoselectivity  in  radical
reactions may be improved by temperature lowering [17, 38],
we  studied  the  chlorohydrostannations  of  1b  at  -78ºC  using
Et3B  as  a  radical  initiator  (Method  B,  Table  3)  but  without
success. We observed longer reaction times, lower yields and
no improvement in the diastereomeric relation. Spectroscopic
characteristics of this bis-chloroorganotin adducts are reported
in the Supporting Information, Tables S5-S8.
All  the  products  obtained,  either  those  enantiomerically
pure (S)-3, (S)-4, (S)-8, (S)-9 or the diastereoisomeric mixtures
5a-d,  6a-d,  10a-d,  11a-d  were  tested  for  antifungal  activity
assays. Despite having separated two diastereoisomers (5a-b),
the mixture of four (5a-d) was used in order to have a uniform
comparison criterion to all diastereomeric mixtures.
4. ANTIFUNGAL ACTIVITY ASSAYS
Compounds S-3, S-4, S-8, S-9, 5a-d, 6a-d, 10a-d and 11a-
d  were  tested  for  antifungal  properties  against  C.  albicans
ATCC 10231 and C. neoformans ATCC 32276 (Table 4). To
assess  antifungal  activities,  the  broth  microdilution  method
M27-A3 for  yeasts  of  the  Clinical  and Laboratory  Standards
Institute was used [39].
The  percentage  of  inhibition  of  each  fungus  was
determined  for  each  compound  at  two-fold  dilutions  in  the
range  250-3.9-µg/mL  where  MIC  and  IC50  (the  minimum
concentration that inhibits 100 and 50% of fungal growth) are
shown  in  the  rightmost  columns.  Amphotericin  B  (Sigma
Aldrich, St Louis, MO, USA) was used as a positive control.
The  results  obtained  in  the  antifungal  assays  against  C.
albicans  and C. neoformans  (Table 4)  allowed us to observe
some trends in the structural-activity relationships: (a) There is
not a clear difference in activity of the compounds against C.
albicans  and C. neoformans  in the case of  (S)-3,  (S)-4,  6a-d
and  5a-d.  For  example,  it  can  be  observed  that  the
diastereomers 6a-d possess an IC50 of 1µg/mL against both the
species, considering that one dilution is the error of the method
[40]. Stereoisomers (S)-3, (S)-4, and 5a-d gave similar values
of IC50 = 250 µg/mL. However, the behavior of (S)-9, 11a-d,
(S)-8 and 10a-d is different. It can be observed that the activity
of the enantiomeric form (S)-9, while is important against both
strains, is lower for C. albicans than for C. neoformans (IC50 =
3.9  µg/mL and  1.9  µg/mL respectively)  while  in  the  case  of
diastereomers 11a-d and enantiomer (S)-8, the IC50 values are
not so good (31.25 and 15.6 µg/mL; 62.5 and 125 µg/mL). In
turn, diastereoisomers 10a-d showed a very good IC50 value of
2  µg/mL for  C.  albicans  but  low activity  for  C.  neoformans
(IC50 = 15.6 µg/mL).(For the sake of clarity see Fig. (5). A and
B).  (b)  If  the  comparisons  are  made  taking  into  account
different  organic  ligands  on  the  Sn  atom,  there  are  clear
differences in the activity: (b1) most compounds with Ph3Sn-
substituents  like  6a-d,  with  IC50  =  1  µg/mL  for  both  fungi
(except for (S)-4  that posseses IC50  = 250 µg/mL) are highly
active compared with those possessing n-Bu3Sn- (5a-d, (S)-3,
IC50 = 250 and >250 µg/mL respectively for both fungi). (b2) A
methyl  group  in  the  alpha  position  (and  therefore  the
introduction of  a  new chiral  center  leading to diastereomers)
shows that the methyl group does not play a clear role in the
antifungal activity. For example, 6a-d possess higher activity
than (S)-4, whereas 11a-d show lower activities than (S)-9. (c)
In contrast with point (b), there are clear differences in activity
when comparing compounds with different substituents on the
Sn atom: (c1) from the compounds containing SnPh3 (6a-d and
(S)-4), 6a-d  is highly active (IC50  values = 1 µg/mL for both
fungi) compared with those possessing SnBu3 ((S)-3 and 5a-d
which showed IC50 = 250 - > 250 µg/mL for both fungi); (c2)
When  one  phenyl  of  SnPh3  is  changed  into  Cl  leading  to
SnPh2Cl ((S)-9 and 11a-d) changes in the activity are observed:
the IC50  of  (S)-9  is  much better  than that  observed for  (S)-4.
However,  when 11a-d  is  compared with 6a-d,  the antifungal
effect is reversed, from an IC50 = 31.25 for C. albicans and 15.6
Table 3. Radical chlorohydrostannation of 1b at -78ºC (Method B).
Entry -R
119SnNMRa Yield
(%)d
Time (hs) %De
(S)b (D)c Cpd. Nº
1 n-Bu -f
72.95
70.09
69.68
68.72
10a-d 40 8
34
16
26
24
2 Ph -f
-63.69
-66.73
-68.68
-70.39
11a-d 65 10
22
29
17
31
a Chemical shift determined in CDCl3 respect to Me4Sn; 
b Single addition adduct; c Double
addition adduct; d Yield of isolated products; e Diastereomeric relationship determined by
integration in the 119SnNMR spectrum of the crude reaction product; f No signals are observed.
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Table 4. Percentages of inhibition of organotin compounds against C. albicans ATCC 10231 (Ca) and C. neoformans ATCC
32264 (Cn).
Structure Fungi
Concentrations (µg/mL)
MICa IC50
a
250 125 62.5 31.2 15.6 7.8 3.9 2 1 0.5
Percentages of Inhibition (%)
Ca
3.5
± 0.8
1.0
± 0.7
0.7
± 0.1
0.6
± 0.0
0.4
±
0.1
0 0 0 0 0 >250 >250
Cn 0 0 0 0 0 0 0 0 0 0 >250 >250
Ca
53.1
± 0.0
28.9
±
1.3
15.8
± 0.1
5.9
± 0.6
4.5
±
0.0
2.7
± 0.2
2.3
±0.4
0 0 0 >250 250
Cn
65.9
± 0.8
46.6
±
0.5
15.8
±
1.9
15.0
±
0.2
9.7
±
0.1
0 0 0 0 0 >250 250
Ca
70.2
± 0.1
18.1
±
1.5
1.73
±
1.8
0.6
± 0.9
0 0 0 0 0 0 >250 250
Cn
39.5
± 0.8
12.6
±
0.2
11.5
±
0.2
9.8
± 0.2
6.6
±
0.2
6.4
±
0.8
5.9
± 0.2
0 0 0 >250 >250
Ca 100 100 100 100 100 100 100
97.1
±
0.0
68.9
±
0.2
21.9
±
0.8
3.9 1
Cn 100 100 100 100 100 100 100 100
68.4
±
0.5
31.1
±
0.5
2 1
Ca 100 100
96.0 ±
1.1
33.0 ±
0.5
29.4
±
0.1
5.1
±
1.0
3.4
±
0.4
0 0 0 125 62.5
Cn
93.1
±
0.8
66.3
±
2.0
30.1 ±
0.3
18.3 ±
0.9
9.4
±
1.3
8.5
±
1.0
8.1
±
1.7
0 0 0 >250 125
Ca 100 100 100 100 100 100 100
32.4
±
0.6
9.6
±
0.1
0 3.9 3.9
Cn 100 100 100 100 100 100 100
52.0
±
1.6
35.7
±
0.3
12.6
±
1.0
3.9 1.9
Ca 100 100 100 100 100 100
85.7
±
0.1
51.4
±
1.0
27.5
±
0.6
3.8
±
0.7
7.8 2
Cn 100 100 100 100
65.4
±
0.6
30.0 ±
0.3
11.5
±
1.1
0 0 0 31.25 15.6
Ca 100 100
93.2
±
0.2
51.8
±
1.7
10.5
±
1.1
3.4
±
0.1
0.7
±
0.7
0 0 0 125 31.25
Cn 100 100
97.4
±
0.9
87.7
± 0.2
49.3
± 0.4
22.4
±
2.2
7.8
±
2.0
0 0 0 125 15.6
Amphotericin B
Ca
Cn
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
1.5
1.5
0.5
0.25
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
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a in µg/mL.
Fig. (5). Comparative curves of the growth inhibition of (A) C. albicans ATCC 10231 and (B) C. neoformans produced by all tested compounds at
different concentrations. Inhibition percentages are the means ± SD obtained from experiments in triplicate.
Fig.  (6).  Comparative  curves  of  the  growth  inhibition  of  (A)  C.  albicans  ATCC  10231  and  (B)  C.  neoformans  produced  by  the  most  active
compounds at concentrations lower than 31.25 µg/mL. Inhibition percentages are the means ± SD obtained from experiments in triplicate.
µg/mL for C. neoformans (11a-d) to an IC50 = 1 µg/mL for 6a-
d in both fungi. (c3) When SnBu3 in (S)-3 and 5a-d is changed
into SnBu2Cl, leading to (S)-8 and 10a-d respectively, the IC50
decreases from IC50 ≥ 250 in (S)-3 to 62.5-125 µg/mL in (S)-8
and from 250 µg/mL in 5a-d to 2-15.6 in 10a-d, the last one
rendering a highly active compound. A comparative curve of
the behavior of the most active structures against C. albicans
and C. neoformans can be observed in Figs. (5 and 6).
CONCLUSION
After all these studies it could be assumed that the spatial
disposition  of  the  unsaturated  ester  groups  linked  to  the  C2
chiral core in (S)-BINOL diesters (S)-1a-e determines that the
radical  addition  of  organotin  hydrides  or  organotin  halo-
hydrides leads to double addition adducts. From the nine pure
organotin  compounds  synthesized  here  with  defined  stereo-
chemistry,  four  of  them  ((S)-3,  (S)-4,  (S)-8  and  (S)-9)  are
enantiomerically pure and four (5a-d, 6a-d, 10a-d and 11a-d)
are diastereoisomeric mixtures. The antifungal properties were
tested  against  two  clinical  important  fungi  with  the  diast-
ereomeric  mixture  6a-d,  being  the  most  active  against  both
strains,  followed  by  the  enantiomer  (S)-9  and  the
diastereomeric  mixture  10a-d.  Interesting  enough,  the  active
compounds  behave  similarly  against  C.  albicans  and  C.
neoformans and some of them possess IC values close to those
of  the  reference  drug.  Regarding  the  most  active  structural
features,  these  compounds  contain  preferably  two  or  three
phenyl  groups  joined  to  the  tin  atom  bonded  to  an
atropoisomeric  core.  Adducts  6a-d,  with  SnPh3  moiety,  are
highly  active  against  both  fungi  compared  with  those
possessing  SnBu3  group.
SUPPLEMENTARY MATERIAL
Supplementary  material  is  available  on  the  publisher's
website  along  with  the  published  article.
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